PURPOSE: ConquerFear is an efficacious intervention for fear of cancer recurrence (FCR) that demonstrated greater improvements than an attention control (relaxation training) in a randomized controlled trial. This study aimed to determine mediators and moderators of the relative treatment efficacy of ConquerFear versus relaxation. METHODS: One hundred and fifty-two cancer survivors completed 5 therapy sessions and outcome measures before and after intervention and at 6 months' follow-up. We examined theoretically relevant variables as potential mediators and moderators of treatment outcome. We hypothesized that metacognitions and intrusions would moderate and mediate the relationship between treatment group and FCR level at follow-up. RESUL...
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clini...
The number of people diagnosed with cancer is steadily increasing while medical advancements have si...
Purpose: Fear of cancer recurrence (FCR) is a major issue in the context of survivorship. The identi...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is prevalent, distressing, and...
Background: Up to 70% of cancer survivors report clinically significant levels of fear of cancer rec...
Background: Up to 70% of cancer survivors report clinically significant levels of fear of cancer rec...
Contains fulltext : 215607.pdf (publisher's version ) (Open Access)PURPOSE: Fear o...
Purpose Fear of cancer recurrence (FCR) is a significantly distressing problem that affects a substa...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is a common problem experience...
Contains fulltext : 170351.pdf (publisher's version ) (Open Access)PURPOSE: In ord...
Purpose: Fear of Cancer Recurrence (FCR) is a common concern for which cancer survivors want profess...
This paper describes the development, content, and preliminary results of a group cognitive-behavior...
The study was supported in part by the Danish Cancer Society, Grant# R150-A10080Purpose Fear of canc...
PURPOSE Fear of cancer recurrence (FCR) is a significantly distressing problem that affects a substa...
BACKGROUND: Fear of cancer recurrence, depressive symptoms, and cancer-related fatigue are prevalent...
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clini...
The number of people diagnosed with cancer is steadily increasing while medical advancements have si...
Purpose: Fear of cancer recurrence (FCR) is a major issue in the context of survivorship. The identi...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is prevalent, distressing, and...
Background: Up to 70% of cancer survivors report clinically significant levels of fear of cancer rec...
Background: Up to 70% of cancer survivors report clinically significant levels of fear of cancer rec...
Contains fulltext : 215607.pdf (publisher's version ) (Open Access)PURPOSE: Fear o...
Purpose Fear of cancer recurrence (FCR) is a significantly distressing problem that affects a substa...
Item does not contain fulltextPurpose Fear of cancer recurrence (FCR) is a common problem experience...
Contains fulltext : 170351.pdf (publisher's version ) (Open Access)PURPOSE: In ord...
Purpose: Fear of Cancer Recurrence (FCR) is a common concern for which cancer survivors want profess...
This paper describes the development, content, and preliminary results of a group cognitive-behavior...
The study was supported in part by the Danish Cancer Society, Grant# R150-A10080Purpose Fear of canc...
PURPOSE Fear of cancer recurrence (FCR) is a significantly distressing problem that affects a substa...
BACKGROUND: Fear of cancer recurrence, depressive symptoms, and cancer-related fatigue are prevalent...
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clini...
The number of people diagnosed with cancer is steadily increasing while medical advancements have si...
Purpose: Fear of cancer recurrence (FCR) is a major issue in the context of survivorship. The identi...